According to the results of multivariable Logistic regression analysis, a nomogram based on Ki-67, therapy cycle, CEA and SII was established to predict pCR after neoadjuvant therapy for breast cancer (Figure 1). Here, CEACAM5 is linked to breast carcinoma.